- News Home
27 November 2013 12:59 pm ,
Vol. 342 ,
The new head of the National Center for Science Education promises to "fight the good fight" against attacks on...
Analyses of the H7N9 strains isolated from four new cases show that the virus is evolving rapidly, heightening anxiety...
In 2009, Jack Szostak shared a Nobel Prize for his part in discovering the role of telomeres, the end bits of...
Science has exposed a thriving academic black market in China involving shady agencies, corrupt scientists, and...
Paper-selling agencies flourish in the aura of reputable businesses. For some scientists, it may be difficult to tell...
Featuring the first lunar rover in 40 years, Chang'e-3 is seen as an important milestone on China's quest to send a...
Data collected by satellites and floating probes have chronicled a 2-decade rise in the temperature and thickness of a...
Cholesterol, the artery-clogging molecule that contributes to cardiovascular disease, has another nasty trick up its...
- 27 November 2013 12:59 pm , Vol. 342 , #6162
- About Us
Nicotine May Help Tourette's Patients
23 February 2000 5:30 pm
WASHINGTON, D.C.--A little nicotine may go a long way toward improving the lives of people with a disease called Tourette's syndrome. Small doses of nicotine can boost the effect of other drugs, allowing patients to lower their dose, neuroscientist Paul Sanberg of the University of Florida, Tampa, reported 21 February at the annual meeting of the American Association for the Advancement of Science, which publishes ScienceNOW.
People with Tourette's syndrome have verbal and muscular tics; they shrug, wave, grimace, or shake their head uncontrollably, and may bark or occasionally blurt out curses. Many of the some 100,000 U.S. children with this syndrome take small doses of powerful antipsychotic drugs such as haloperidol to control these symptoms. But the drugs also slow thinking and movement, and have other serious side effects such as dizziness, headache, and dehydration.
Over the past decade, Sanberg and others had gathered anecdotal evidence that low doses of nicotine from patches or gum improve the tic-calming potential of other drugs, an effect also seen in rats. These observations suggested that children could cut their total drug intake by adding just a little nicotine to their regimen. "We're not talking about tobacco," Sanberg emphasizes.
To test that hypothesis, Sanberg and his colleagues enrolled 70 children aged 8 to 17 in a double-blind trial; half of them wore skin patches releasing 7 milligrams of nicotine a day for 8 weeks, while the other half wore placebo patches. All continued to take their medication. The first group behaved much more normally, having fewer tics and verbal outbursts, Sanberg reported. Even when the participants' haloperidol dose was lowered midway through study, "the level of improvement was maintained." Sanberg declined to reveal details of the study because the data have not yet been published.
The study did not suggest that the children become addicted to nicotine, nor has any previous trial. But there were minor side effects, such as upset stomach and itching caused by the patch. Sanberg and others are now trying to find nicotinelike substances without these side effects that could be taken orally.
The medical community has been eagerly awaiting the data, says Gerald Erenberg, a pediatric neurologist at the Cleveland Clinic Foundation in Ohio. But "because nicotine has been looked at as such a villain, we're conservative about the results," he says. Erenberg says he hopes the study will be replicated by other researchers.